Balkrishna Paper Mills Limited
BALKRISHNA · NSE · Consumer Cyclical
StocksWizard rates Balkrishna Paper Mills Limited a Strong Sell, scoring 11/100 on our blended model. At ₹18.12 there isn't enough clean financial data for a confident fair-value estimate, so we hold back an intrinsic verdict here. Financial health scores 0/100 (grade F), with a Piotroski F-score of 2/9. It clears 0 of 7 investability checks, with durability 0, valuation 15 and momentum 32 on our 0–100 scales.
These are StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
Piotroski F-score 2/9 — quality of earnings & balance sheet.
Investability checklist
- –ROE above 15%
- –Low debt (D/E < 0.5)
- ✕Positive free cash flow
- ✕Revenue growth > 10%-47%
- –Earnings growing
- ✕Net margin ≥ 10%-137.7%
- ✕Current ratio > 1.50.53
- –Below our fair value
- –Margin of safety ≥ 20%
- ✕Above 200-day average
- ✕Above 50-day average
- –Positive 1-year return
- –Altman Z in safe zone
- ✕Piotroski ≥ 72/9
1-year price
EOD · 2026-06-19Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Shareholding
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
SWOT snapshot
Weaknesses
- •Price below its 200-day moving average (downtrend).
- •Weak Piotroski score (2/9).
Threats
- •Rich valuation versus sector peers.
About Balkrishna Paper Mills Limited
Balkrishna Paper Mills Limited engages in the manufacture and sale of paper and paper boards primarily in India. It operates through the Paper and Paper Board, and Trading of Plastic & Packaging Materials segments. The company offers eco, chromo white back, eco-white, eco kraft back, and duplex coated boards
More in Consumer Cyclical
All stocksOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.